MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Tesla
TSLA
Amazon
AMZN
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 31.430
- -0.850-2.63%
Close Jan 17 16:00 ET
- 32.920
- +1.490+4.74%
Pre 05:01 ET
4.96BMarket Cap-12.88P/E (TTM)
32.950High31.400Low1.37MVolume32.290Open32.280Pre Close43.52MTurnover0.88%Turnover RatioLossP/E (Static)157.90MShares52.49052wk High7.49P/B4.92BFloat Cap31.40052wk Low--Dividend TTM156.51MShs Float86.582Historical High--Div YieldTTM4.80%Amplitude2.500Historical Low31.661Avg Price1Lot Size
Ionis Pharmaceuticals News
Wells Fargo Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $77
Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Ionis Pharmaceuticals (IONS) Gets a Hold From Bernstein
Ionis Pharmaceuticals Analyst Ratings
RBC Capital Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $70
RBC Capital Sticks to Its Buy Rating for Ionis Pharmaceuticals (IONS)
Citi Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $67
Wells Fargo Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $77
Ionis Pharmaceuticals: Strategic Path to Cash Flow Positivity and Strong Pipeline Drive Buy Rating
Morgan Stanley Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $55
Ionis Pharmaceuticals: Hold Rating Amid Uncertainty in Future Financial Performance
Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $51
Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)
Piper Sandler Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $62
Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Maintains Target Price $51
Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)
A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $59 to $67
Ionis Pharmaceuticals Analyst Ratings
Oppenheimer Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $75
TD Cowen Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $59
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.